PURPOSE: Because several macular dystrophies are caused by mutations in the peripherin/RDS gene, we examined autosomal dominant and spo radic cases of central areolar choroidal dystrophy for mutations in the peripherin/RDS gene. METHODS: D N A sequence analysis of the periph erin/RDS gene was performed in four sporadic cases and in ten affected and nine unaffected individuals from seven families with autosomal dominant central areolar choroidal dystrophy. RESULTS: An Arg-142-Trp mutation in the peripherin/RDS gene was found in ten affected family members in seven families. Among these, a 69-year-old man with the Arg-142-Trp mutation, who was unaffected six years before blood sample analysis, showed a parafoveal area of chorioretinal atrophy. The 65-year-old sister of this family had the Arg-142-Trp mutation with no macular abnor malities, but she might still develop central areolar choroidal dystrophy at an older age. No mutation was found in the four sporadic cases. • CONCLUSION: Autosomal dominant central areolar choroidal dystrophy, studied in seven fami-The Netherlands; fax i 1-24^540522. lies, is caused by an Arg-142-Trp mutation in the peripherin/RDS gene. 2 ENTRAL AREOLAR CHOROIDAL DYSTROPHY IS A
hereditary disorder of the macula leading to a well-demarcated circumscribed area of atrophy of the pigment epithelium and choriocapillaris. Sorsby1 was the first to describe the genetic nature of central areolar choroidal dystrophy. In 1955, Sandvig a family with dominant segregation of central areolar choroidal dystrophy, citing 13 cases spread over four generations. The classic signs and symptoms usually develop between the ages of 40 and 60 years, leading to a central scotoma and visual impairment. Results of retinal functional analysis, by means of electroretinography, electro-oculography, subjective dark adaptation measurement, and color vision examination, are generally normal; however, in advanced cases, color vision is disturbed. 1 The early stages of characterized by a fine, sometimes hardly detectable, mottling of the parafo veal pigment epithelium. In younger children whose parent has autosomal dominant central areolar cho roidal dystrophy, t hese changes are often not present. 4 Various mutations in the retinal degeneration slow gene, which codes for peripherin/RDS, have been . 'd in patients with retinitis pigmentosa, macu lar dystrophy, pattern dystrophy, fundus fl latus, and butterfly-shaped Wroblewski ; codon 172 ii lystrophy,5'11 reported mutations in In those patients, the area of choroidal atrophy was larger than the area of atrophy found in central Vol. 121, No. f. areolar choroidal dystrophy. Furthermore, loss of rod function was found in the dark-adapted rod electroretinogram. The phenotypic resemblance between macular dystrophy and central areolar choroidal dys trophy and the finding that the peripherin/RDS gene is the only gene in which mutations have been shown to be responsible for macular dystrophies prompted us to investigate the involvement of the peripherin/ RDS gene in the onset of central areolar choroidal dystrophy.
PATIENTS AND METHODS

IN SEVEN FAMILIES WITH AUTOSOM AL DOMINANTLY IN-
herited central areolar choroidal dystrophy ( Fig. 1 ), we found 30 affected individuals with fundus changes ranging from slight parafoveal depi typical end stage, in which there is a well area of atrophy of pigment epithelium and c illaris in the posterior pole. From these f collected blood samples from ten affected i s to the arcated ,\s. we Genomic DNA was isolated from peripheral blood, as described elsewhere.IS For mutation analysis, 25 ng of genomic DNA of all family members who were studied and the four patients with sporadic disease was subjected to 30 cycles of polymerase chain reaction. Part of exon 1 of the RDS amplified with the following primers: forward, 5' GCCAAGTATGCCAGATGGAAG-3 ' from the middle of exon 1); reverse, 5'-ATAGCT-CTGACCCCAGACTG-3 ' (derived from the 5' end of intron l). 16 Polymerase chain reaction conditions was were as follows: initial aturation 5' at 95 C, dénaturation for one minute at 95 C, annealing for one minute at 58 C, extension for one and a half minutes at 72 C, and a final extension for five minutes at 72 C. After am ication, re--«' were pun polymerase chain on a Microcan column (Amicon, Inc., Beverly, Massachusetts). The same primers were end-labeled with gamma-''P dATP and were used for cycle sequencing according to the protocol provided by the Rethesda Research Lahoratories.
To screen for the presence of (he mutation in a population sample, an allele-specific oligohyhridizahy u sin g th e follow in g prim* d o n 142 (Fig. 4) . To test this base pair change could be correlated with onset: o f the disease or should be considered to be a polymorphism in t h e population, we a n t e o mutation. In total, 2 general ligohybridization test to detect this Hroinosomes were tested from In none of these chromoton.
X X K 'iG A C -V , and m utat-
ers: normal, 5'-GTAC , 5 '-G T A C T A C T C ÏÜ C îA C A -V . I Iyhridi
somes was the mutation detected. Subsequently, blood samples were collected from additional family members and four unrelated patients with a similar phenotype. The mutation was detected in all affected family members who were available (N = 10) and was not present in seven of nine family members without visual complaints. Two individuals older than 50 years who had the mutation showed no sign of macular degeneration at the time of the initial diagnosis. In one of these patients (Gu III-5; male; age, 69 years), ophthalmos copy performed in 1988 disclosed no fundus abnor malities. Because of the traveling distance to our institute and because his poor physical condition did not permit him to visit us for réévaluation, we requested another ophthalmoscopic examination. He sent us Polaroid pictures taken with a nonmydriatic camera by his optician (Fig. 5 ). These pictures clearly showed an atrophic lesion of the posterior pole with sparing of the fovea, confirming our findings on the DNA level. The second individual (Gu III-8; female; age, 65 years) with the mutation agreed to have a reexamination. Visual acuity was 20/20 in both eyes. Ophthalmoscopy and fluorescein angiography showed no abnormalities in the posterior pole.
In the four sporadic cases without family history of central areolar choroidal dystrophy, no mutations were observed in the complete screening of the coding region of the peripherin/RDS gene (data not shown). and an Arg-172-Gln mutation was found in one family with macular dystrophy. '1,12 The phenotype of central areolar choroidal dystro-RDS gene. This base pair change leads to a substitu tion from arginine to tryptophan (Arg-142-Trp). Similar to most other mutations that have been reported so far for other macular dystrophies, the mutation in central areolar choroidal dystrophy is located in the second interdiskal loop of the peripherin molecule.18 Three other mutations are located in the transmembrane segments 1, 3, and 4.18 The function of the peripherin molecule is unknown, but it has been suggested that it functions as an adhesion molecule, stabilizing outer or heterophilic interactions interdiskal space. The second intradiskal loop of the peripherin protein is located extracellularly and prob ably is involved in these interactions.
DISCUSSION
RETINITIS PIGMENTOSA, AS WELL AS S E V E R A L DYSTROphies of the macula, has been associated with muta tions of the peripherin/RDS gene. A Pro-216-Ser mutation was demonstrated in a family with retinitis
In one 65-year-old patient (Gu III-8), the Arg-142-Trp mutation was found, although no macular chang es were observed on fluorescein angiography. Howev er, as in her brother (Gu HI-5), in whom the atrophy became manifest between the ages of 63 and 69 years, central areolar choroidal dystrophy could still develop at an older age.
In the four sporadic cases, no mutation was found in the regulatory region of the peripherin/RDS gene. Either the phenotype was caused by a mutation in the noncoding region of the peripherin/RDS gene or by a mutation in a different gene. In these families we found no other affected individuals. Therefore, it was not p to mine the •'•'ase in phy in our • I t clearly from those of fundus flavimaculatus,9 pattern dystrophy,8,9 and but terfly dystrophy.7,10,11 No typical flecks or patternlike hyperpigmentations were observed in our patients. The phenotype of macular does show to central areolar choroidal dystrophy. Severe visual loss in siblings from families \ 4 with macular dystrophy developed before the 40 years. Although atrophy of the retinal pigment epithelium was demonstrated early in their lives, in our family members, disabling decrease of vision generally developed in their seventh decade, when these patients is linked to the peripherin/RDS In conclusion, we found an Arg-142-Trp mutation in seven families with autosomal dominant central areolar choroidal dystrophy. Although from our earli er studies penetrance was estimated to be 100% above the age of 50 years, we found one individual who carried the mutation but had not developed any signs of central areolar choroidal dystrophy at: the age of 65 years. Her affected brother developed signs of cent ral ar choroidal dystrophy between the ages of and 69 years. ■ ji* « w m m aM »igfigpn the atrophy the fovea. Furthermore, the atrophic macular lesions in our patients were smaller and not connected to the optic disk.
In all the blood samples were family from whom , a change from C to T was found at position 664, resulting in a change of codon 142 from CGG to TG G in the peripherin/
